|
|
|
|
||
Re: Minerva Neurosciences to Present at JMP Securities CNS ForumRemy: “Story is becoming more compelling” “Can’t go into details” Looking at “totality of data from Phase 2B and 3” “Nine month extension has been completed by many patients” (sounds like they have a lot of anecdotal evidence of improved functionality in this group) Remy tried to make the point that they would be making their case to the FDA with more than “post hoc” analysis (I don’t understand how that’s possible). The most interesting Remy quote and I believe a potential SP driver came 20:35 into the interview: “I don’t believe we have to run a study” I continue to hold a modest position. https://wsw.com/webcast/jmp44/nerv/1692565 |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
693 | Re: Minerva Neurosciences to Present at JMP Securities CNS Forum | Paul777333 | 2 | 8/19/2020 12:37:18 PM |